Skip to main content
SpringerLink
Log in

Induction of microsomal triglyceride transfer protein expression is a candidate mechanism by which ezetimibe therapy might exert beneficial effects in patients with nonalcoholic steatohepatitis

  • Letter to the Editor
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Park H, Shima T, Yamaguchi K, Mitsuyoshi H, Minami M, Yasui K, et al. Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease. J Gastroenterol. 2011;46:101–7.

    Article  PubMed  CAS  Google Scholar 

  2. Altmann SW, Davis HR Jr, Zhu LJ, Yao X, Hoos LM, Tetzloff G, et al. Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science. 2004;303:1201–4.

    Article  PubMed  CAS  Google Scholar 

  3. Muraoka T, Aoki K, Iwasaki T, Shinoda K, Nakamura A, Aburatani H, et al. Ezetimibe decreases SREBP-1c expression in liver and reverses hepatic insulin resistance in mice fed a high-fat diet. Metabolism [Epub ahead of print].

  4. Nomura M, Ishii H, Kawakami A, Yoshida M. Inhibition of hepatic Neiman-Pick C1-Like 1 Improves hepatic insulin resistance. Am J Physiol Endocrinol Metab [Epub ahead of print].

  5. Yoneda M, Fujita K, Nozaki Y, Endo H, Takahashi H, Hosono K, et al. Efficacy of ezetimibe for the treatment of non-alcoholic steatohepatitis: an open-label, pilot study. Hepatol Res. 2010;40:613–21.

    Article  PubMed  Google Scholar 

  6. Fujita K, Nozaki Y, Wada K, Yoneda M, Fujimoto Y, Fujitake M, et al. Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis. Hepatology. 2009;50:772–80.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (22790660) to M.Y.

Author information

Authors and Affiliations

  1. Division of Gastroenterology, Yokohama City University Hospital, Yokohama, Japan

    Masato Yoneda, Koji Fujita, Kento Imajo, Hironori Mawatari, Hiroyuki Kirikoshi, Satoru Saito & Atsushi Nakajima

Authors
  1. Masato Yoneda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Koji Fujita
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kento Imajo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hironori Mawatari
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hiroyuki Kirikoshi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Satoru Saito
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Atsushi Nakajima
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Atsushi Nakajima.

Additional information

An answer to this letter to the editor is available at doi:10.1007/s00535-010-0357-7.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yoneda, M., Fujita, K., Imajo, K. et al. Induction of microsomal triglyceride transfer protein expression is a candidate mechanism by which ezetimibe therapy might exert beneficial effects in patients with nonalcoholic steatohepatitis. J Gastroenterol 46, 415–416 (2011). https://doi.org/10.1007/s00535-010-0356-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-010-0356-8

Keywords

Search

Navigation